Categories
FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live). FDA Removes Recommended Pause in Use and Approves Required Updated Labeling: FDA Safety Communication
Categories
On World Breastfeeding Week, countries urged to invest in health systems and support breastfeeding mothers
On World Breastfeeding Week, countries urged to invest in health systems and support breastfeeding mothers
Oscar Reyes
6 Aug 2025
Categories
PAHO presents its 2024 country reports, highlighting concrete results of its technical cooperation in health in the Americas
PAHO presents its 2024 country reports, highlighting concrete results of its technical cooperation in health in the Americas
Oscar Reyes
6 Aug 2025
Categories
Early Alert: Defibrillation Lead Issue from Boston Scientific
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program
Categories
Early Alert: Electrophysiology Catheter Issue from Medline ReNewal
Recall affects certain Medline ReNewal Reprocessed St. Jude Medical Response Diagnostic Electrophysiology Catheters and Supreme Electrophysiology Catheters
Categories
Early Alert: WATCHMAN Access System Issue from Boston Scientific
Boston Scientific has issued a letter to affected customers recommending all lots of certain WATCHMAN Access Systems have updated use instructions
Categories
Continuous Ventilator Correction: Philips Respironics Updates Use Instructions for BiPAP A30, A40, and V30 Devices Due to Interruptions and/or Loss of Therapy
BiPAP A30, A40, and V30 devices may shut down due to a Ventilator Interruptions, leading to therapy loss. May cause serious injury or death.
Categories
FDA Names Top HHS Lawyer as Chief Counsel
FDA Names Top HHS Lawyer as Chief Counsel
http://www.fda.gov/news-events/press-announcements/fda-names-top-hhs-lawyer-chief-counsel
Categories
FDA is Requiring Opioid Pain Medicine Manufacturers to Update Prescribing Information Regarding Long-Term Use: Drug Safety Communication
FDA is Requiring Opioid Pain Medicine Manufacturers to Update Prescribing Information Regarding Long-Term Use. Class-Wide Action Will Further Emphasize and Characterize Risks of Long-Term Use to Help Patients, Health Care Professionals Make Informed Treatment Decisions: Drug Safety Communication
Categories
FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
http://www.fda.gov/news-events/press-announcements/fda-requires-major-changes-opioid-pain-medication-labeling-emphasize-risks